-The Hindu We need to take AIDS out of isolation and look at it in a broader framework, with links to maternal and child health, says Michel Sidibe, Executive Director of UNAIDS. Speaking on the sidelines of the India Africa Forum Summit, Michel Sidibe, Executive Director, UNAIDS, admitted to being ‘scared’ as pressure mounts on India to relax norms, allowing patent protection. In a conversation with Vidya Krishnan, Mr. Sidibe also spoke...

-The Times of India There has been a steady decline in India's overall sex ratio (SR) over the 20th century. The 1975 Report of the Committee of the Status of Women drew attention to the fact that while the 1901 census showed 972 females per thousand males, this had declined steadily to 946 in 1951, 941 in 1961, and 930 in 1971. The 1981 census, however, threw up a happy figure of...

-Rediff.com Potshangbam Devakanta from Manipur shows the way in conserving the biodiversity of the state, farming around 100 traditional varieties of paddy and rare medicinal plants, finds Manu A B/Rediff.com. When farmers across India are grappling with weather woes and poor yields, Potshangbam Devakanta from Manipur has succeeded in adopting smart and eco-friendly methods of farming to ensure his harvest is satisfactory year after year. Like thousands of farmers in India, 60-year-old Devakanta...

-The Times of India Dr David Berger, director of the British Medical Journal group and a general physician practising in Australia, is better known in India for an article he wrote in the BMJ in May last year titled 'Corruption ruins the doctor-patient relationship in India' based on his experiences of working in India. The article sparked a public debate on the widespread corruption in India's healthcare sector. Here now on...

-The Times of India MUMBAI: Certain medicines are being aggressively marketed in India despite inadequate evidence of safety and efficacy, putting patients at risk, said reputed medical journal Lancet. Highlighting weak regulation and monitoring of the domestic drug industry, three recently-introduced medicines are being prescribed and sold though there is a lack of rigorous trials on crucial safety and efficacy parameters. The pharmaceutical industry in India should face the same stringent regulations...